Detalles de la búsqueda
1.
Prevalence of hyperhomocysteinaemia and some of its major determinants in Shaanxi Province, China: a cross-sectional study.
Br J Nutr
; 113(4): 691-8, 2015 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634595
2.
Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China.
Biomed Environ Sci
; 27(5): 325-34, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24827713
3.
Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables.
BMC Public Health
; 13: 602, 2013 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23800082
4.
[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study].
Zhonghua Nei Ke Za Zhi
; 52(1): 11-5, 2013 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-23710808
5.
[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].
Zhonghua Nei Ke Za Zhi
; 52(11): 932-5, 2013 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-24439186
6.
[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study].
Zhonghua Nei Ke Za Zhi
; 51(12): 957-61, 2012 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-23327957
7.
[A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China].
Zhonghua Nei Ke Za Zhi
; 49(8): 662-6, 2010 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-20979784
8.
[A comparison of the efficacy and safety of domestic orlistat and imported orlistat in Chinese overweight and obese patients].
Zhonghua Nei Ke Za Zhi
; 48(10): 825-9, 2009 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-20079223
9.
[Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices].
Zhonghua Yi Xue Za Zhi
; 89(16): 1117-21, 2009 Apr 28.
Artículo
en Zh
| MEDLINE | ID: mdl-19595144
10.
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2).
Diabetes Ther
; 10(4): 1435-1452, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228090
11.
[Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 30(2): 211-3, 2008 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-18505128
12.
Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.
Chin Med J (Engl)
; 126(3): 457-63, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23422107
13.
[Expression of glucagon in gestational and diet-induced hyperlipidemic gestational rats].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
; 26(4): 359-62, 2010 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-20368116
14.
[Association of urinary albumin excretion rate and hyperuricemia with macrovascular atherosclerosis in type 2 diabetic patients].
Nan Fang Yi Ke Da Xue Xue Bao
; 30(1): 140-2, 2010 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-20118005
15.
A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
Chin Med J (Engl)
; 122(24): 2933-8, 2009 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20137477
16.
Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
Chin Med J (Engl)
; 122(14): 1704-8, 2009 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19719975
Resultados
1 -
16
de 16
1
Próxima >
>>